Skip to main content
. 2020 Nov 10;19:190. doi: 10.1186/s12933-020-01164-8

Fig. 4.

Fig. 4

Expected benefit of recommended LDL-c reduction. Panel a and b shows the absolute risk reduction achievable with treatments aimed to reach LDL-c targets in each group stratified by starting LDL-c levels (number in brackets are the proportion of subjects each group over the entire population). Panel c Expected number of subjects experiencing CVD events over 10 years (/100,000 subjects) in case of unchanged or changed cholesterol-lowering treatments